Efficacy and Safety of Guilingji Capsules (龟龄集胶囊) for Treating Mild-to-Moderate Cognitive Impairment: Study Protocol for A Randomized, Double-Blind, Positive-Controlled, Multicenter and Noninferiority Trial
Crossref DOI link: https://doi.org/10.1007/s11655-020-2723-5
Published Online: 2020-08-05
Published Print: 2020-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Nan-yang
Pei, Hui
Liu, Mei-xia
Liu, Long-tao
Fu, Chang-geng
Li, Hao
Chen, Ke-ji
Text and Data Mining valid from 2020-08-01
Version of Record valid from 2020-08-01
Article History
Accepted: 26 April 2019
First Online: 5 August 2020